EUVIMEDScopri EUVIMED
Leserbrief

Letter: Reconsidering Tenofovir Disoproxil Fumarate Use in Light of Emerging Safety Evidence—Authors' Reply

Grace L H Wong iD, Edward Gane iD, Wan-Long Chuang iD, Maria Buti, Study Team

Alimentary Pharmacology & Therapeutics · 2026-07 · 64 (2) · 285-286

DOI: 10.1111/apt.70789 ↗

At a glance

Leserbrief in Alimentary Pharmacology & Therapeutics, published online on 2026-06-10. Written by Grace L H Wong and 4 co-authors. Institution: Department of Medicine and Therapeutics, Medical Data Analytics Centre (MDAC), The Chinese University of Hong Kong, Hong Kong, SAR, China. 8 references.

AbstractDati bibliograficiCiteRelated studies

Abstract (original language)

Abstract non disponibile.

Authors and institutions

  • Department of Medicine and Therapeutics, Medical Data Analytics Centre (MDAC), The Chinese University of Hong Kong, Hong Kong, SAR, China.
  • Faculty of Medicine, University of Auckland, Auckland, New Zealand.
  • Hepatobiliary Division, Department of Internal Medicine and Hepatitis Research Center, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.
  • Hospital Universitario Vall D'hebron and CIBEREHD del Instituto Carlos III, Barcelona, Spain.

ORCID profiles: Grace L H Wong, Edward Gane, Wan-Long Chuang

Cite

APA

Wong, G. L. H., Gane, E., Chuang, W. L., Buti, M., & Study Team (2026). Letter: Reconsidering Tenofovir Disoproxil Fumarate Use in Light of Emerging Safety Evidence—Authors' Reply. Alimentary Pharmacology & Therapeutics, 64(2), 285-286. https://doi.org/10.1111/apt.70789

Vancouver

Wong GLH, Gane E, Chuang WL, Buti M, Study Team. Letter: Reconsidering Tenofovir Disoproxil Fumarate Use in Light of Emerging Safety Evidence—Authors' Reply. Alimentary Pharmacology & Therapeutics. 2026;64(2):285-286. doi:10.1111/apt.70789

BibTeX
@article{Wong2026,
  author = {Wong, Grace L H and Gane, Edward and Chuang, Wan-Long and Buti, Maria and Study Team, Study Team},
  title = {Letter: Reconsidering Tenofovir Disoproxil Fumarate Use in Light of Emerging Safety Evidence—Authors' Reply},
  journal = {Alimentary Pharmacology & Therapeutics},
  year = {2026},
  volume = {64},
  number = {2},
  pages = {285--286},
  doi = {10.1111/apt.70789}
}
Start for free →